Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management-Reference-Cited by-同舟云学术

Dupilumab-induced hypereosinophilia: review of the literature and algorithm proposal for clinical management

Published:2022-06-23 Issue:7 Volume:16 Page:713-721
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Caminati Marco¹^ORCID,Olivieri Bianca¹,Dama Annarita²,Micheletto Claudio³,Paggiaro Pierluigi⁴^ORCID,Pinter Patrick⁵,Senna Gianenrico¹²,Schiappoli Michele²

Affiliation:

1. Department of Medicine, Asthma, Allergy and Clinical Immunology Section, University of Verona, Verona, Italy

2. Allergy and Asthma Unit, Verona University Hospital, Verona, Italy

3. Respiratory Medicine Unit, Verona University Hospital, Verona, Italy

4. Department of Surgery, Medicine, Molecular Biology and Critical Care, University of Pisa, Pisa, Italy

5. Division of Otorhinolaryngology, Department of Surgery, Dentistry, Gynecology, and Pediatrics, University of Verona, Verona University Hospital, Verona, Italy

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2022.2090342

Reference53 articles.

1. Mechanisms of Dupilumab

2. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

3. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

4. Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial

5. Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effectiveness and Reasons for Discontinuation of Dupilumab in Patients With Atopic Dermatitis;JAMA Dermatology;2024-08-07

2. Real‐world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years;Allergy;2024-08-07

3. Prolonged hypereosinophilia associated with dupilumab for atopic dermatitis: A case series and review of literature;JAAD Case Reports;2024-08

4. Efficacy of Biologics in Patients with Allergic Bronchopulmonary Aspergillosis: A Systematic Review and Meta-Analysis;Lung;2024-06-19

5. Feasibility of continued treatment with dupilumab in patients with type 2 inflammatory disease who developed eosinophilic pneumonia: 3 case reports;Respirology Case Reports;2024-06